MedDataX Logo

A Registry Study of Runzaozhiyang Capsule Used in Clinical Real World

NCT ID: NCT03192748

Last Updated: 2017-06-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-06-19

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is get to know what and how Runzaozhiyang capsule in hospital results in drug-induced liver injury or adverse drug reactions from a cohort event monitoring as registration research.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic Eczema

NCT02601222

Chronic Eczema
UNKNOWN PHASE4

The Safety and Effectiveness of Local Injection of Antihistamines in Treatment of Inflammatory Skin Diseases

NCT04937101

Inflammatory Skin Disease
UNKNOWN NA

Study of the Intradermal Injection of rHuPH20 or Placebo in Participants With Nickel Allergic Contact Dermatitis

NCT00928447

Dermatitis, Allergic Contact
COMPLETED PHASE2

An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea

NCT03352323

Rosacea Erythema
COMPLETED PHASE3

Evaluation the Effectiveness of Ru-Yi-Jin-Huang Powder for the Radiation-induced Dermatitis.

NCT04888234

Radiation Dermatitis
UNKNOWN PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In order to improving monitoring drug-induced liver injury or adverse drug reactions of Chinese medicine containing Radix Polygoni Multiflori in clinical real world, registry study is suitable method in this area. Otherwise, nested case control study is used to find out the mechanism of drug-induced liver injury. Calculate the incidence of drug-induced liver injury or adverse drug reactions is one of the main aims for this study. Safety surveillance on Chinese medicine containing Radix Polygoni Multiflori is an important problem that needs to be sorted out through large sample observational study. According to the relevant regulations of the CFDA, 3000 cases need to be registered at least. The aim population is who using Runzaozhiyang capsule 's with abnormal liver function before medication from June 2017 to June 2019.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eczema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients using Runzaozhiyang capsule 's with abnormal liver function before medication from June 2017 to June 2019.

Exclusion Criteria

none
Minimum Eligible Age

1 Hour

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Xiyuan Hospital of China Academy of Chinese Medical Sciences

OTHER

Sponsor Role collaborator

China Academy of Chinese Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yanming Xie

Deputy director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yanming Xie, BA

Role: PRINCIPAL_INVESTIGATOR

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yanming Xie, BA

Role: CONTACT

[email protected]
86-13911112416

Lianxin Wang, doctor

Role: CONTACT

[email protected]
86-13521781839

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Runzao

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment
NCT04358224 COMPLETED PHASE4
Molecular Diagnosis of Allergic Contact Dermatitis (SMECA).
NCT06124781 RECRUITING NA
Severe Cutaneous Adverse Reactions in Thailand
NCT02574988 UNKNOWN
Dermatological Evaluation of Topical Compatibility, Primary Skin Irritability, Accumulated Skin Irritability, and Dermal Sensitisation
NCT02419248 COMPLETED
Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
NCT00645164 COMPLETED PHASE1
Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction.
NCT03166241 UNKNOWN NA
Black Tea Compresses for Facial Eczema and Perioral Dermatitis
NCT02941432 COMPLETED NA
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
NCT00644917 COMPLETED PHASE1
A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
NCT01182025 UNKNOWN NA
Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore Individuals
NCT06454942 RECRUITING NA
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
NCT02932891 COMPLETED PHASE2
A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients
NCT04369846 COMPLETED PHASE1/PHASE2
Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.
NCT03458624 UNKNOWN
Xia Shi Surgical Treatment for Eczema Multi-center Clinical Research
NCT02517957 UNKNOWN PHASE2
Survey on Itch in Outpatients of a University Clinic
NCT03901443 COMPLETED
Evaluating the Feasibility of High-volume, Low-risk Penicillin Allergy De-labelling to Maximise Efficiency in a Resource-limited Setting
NCT06532448 NOT_YET_RECRUITING NA
Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)
NCT03176342 UNKNOWN NA
Prediction of Rituximab Hypersensitivity and Desensitization Treatment
NCT04610242 UNKNOWN NA
Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration
NCT02493283 COMPLETED PHASE1
Clinical Observations of Pain and Pruritus Induced by Exposure to Allergic Contact Dermatitis Caused by Macrolides
NCT06574204 NOT_YET_RECRUITING
Does Topical Steroid Treatment Impair the Adrenal Function?
NCT00476489 UNKNOWN
A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
NCT01175915 UNKNOWN NA
A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 2
NCT04611971 COMPLETED PHASE1
Skin Tests in Cat Allergic Patients With Cat Dander Samples Obtained Before and After Vaccinating the Cat
NCT02667379 COMPLETED NA
Evaluation of Efficacy and Safety of Enhanced External Counter-pulsation on Patients With Atopic Dermatitis and Inflammatory Skin Disease Requiring Wet Wrap Therapy
NCT06448702 NOT_YET_RECRUITING NA